《Future Medicinal Chemistry》雜志的最新年發文量為127篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在藥物化學領域的學術影響力。
該刊聚焦于醫學-藥物化學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 偏慢,4-8周 。
Future Medicinal Chemistry 雜志發文統計
文章名稱引用次數
- Atropisomerism in medicinal chemistry: challenges and opportunities30
- Anticancer metallodrugs: where is the next cisplatin?26
- Deep learning for molecular generation21
- Carbonic anhydrase activators20
- PAAP: a web server for predicting antihypertensive activity of peptides16
- Translational role of natural coumarins and their derivatives as anticancer agents14
- Deep learning and virtual drug screening13
- Thiazole in the targeted anticancer drug discovery13
- Mn(II) compounds as an alternative to Gd-based MRI probes13
- Metal-based antitumor compounds: beyond cisplatin13
國家/地區發文量
- CHINA MAINLAND138
- USA114
- Italy62
- India56
- Egypt44
- Spain39
- England35
- Brazil30
- GERMANY (FED REP GER)29
- Australia24
